Skip to main content
OpenTrials

Clinical trial condition

de Novo DLBCL

Explore clinical trials studying de Novo DLBCL. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

de Novo DLBCL trial results

Completed

Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant

NCT01321541

Conditions
DLBCL Transformed From Indolent Lymphoma, Diffuse Large B-cell Lymphoma, Disease Attributes, +17 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Highlands Oncology Group Bentonville, Arkansas, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
View all 131 locations
View Trial Details

Related conditions